Your browser doesn't support javascript.
loading
Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia.
Qian, Fenghua; Arner, Brooke E; Kelly, Kathleen M; Annageldiyev, Charyguly; Sharma, Arati; Claxton, David F; Paulson, Robert F; Prabhu, K Sandeep.
Affiliation
  • Qian F; Department of Veterinary & Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Arner BE; Center for Molecular Immunology and Infectious Disease and Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Kelly KM; Department of Veterinary & Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Annageldiyev C; Center for Molecular Immunology and Infectious Disease and Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Sharma A; Department of Veterinary & Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Claxton DF; Center for Molecular Immunology and Infectious Disease and Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Paulson RF; Mammalian Pathology Section, Animal Diagnostic Laboratory, Department of Veterinary & Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • Prabhu KS; Division of Hematology and Oncology, Penn State Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
FASEB J ; 36(5): e22328, 2022 05.
Article in En | MEDLINE | ID: mdl-35471732
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Prostaglandin D2 / Interleukin-4 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Prostaglandin D2 / Interleukin-4 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article